OIZUMI Corporation
TSE:6428 Stock Report
OIZUMI Balance Sheet Health
Financial Health criteria checks 3/6 OIZUMI has a total shareholder equity of ¥18.4B and total debt of ¥17.4B, which brings its debt-to-equity ratio to 95%. Its total assets and total liabilities are ¥41.9B and ¥23.6B respectively. OIZUMI's EBIT is ¥1.0B making its interest coverage ratio 13.4. It has cash and short-term investments of ¥8.0B.
Key information
95.0%
Debt to equity ratio
Interest coverage ratio 13.4x Cash JP¥8.00b Equity JP¥18.36b Total liabilities JP¥23.59b Total assets JP¥41.94b
Recent financial health updates
Show all updates
OIZUMI Corporation to Report Q2, 2025 Results on Nov 13, 2024 Sep 14
Investor Optimism Abounds OIZUMI Corporation (TSE:6428) But Growth Is Lacking Aug 07
Investor sentiment deteriorates as stock falls 20% Aug 05
OIZUMI Corporation to Report Q1, 2025 Results on Aug 09, 2024 Jul 06
Full year 2024 earnings released: EPS: JP¥23.47 (vs JP¥69.39 in FY 2023) May 16
OIZUMI Corporation, Annual General Meeting, Jun 27, 2024 May 15
OIZUMI Corporation to Report Fiscal Year 2024 Results on May 13, 2024 Mar 29
Upcoming dividend of JP¥12.00 per share Mar 21
Third quarter 2024 earnings released: JP¥5.29 loss per share (vs JP¥2.31 profit in 3Q 2023) Feb 15
New minor risk - Share price stability Feb 14
OIZUMI Corporation to Report Q3, 2024 Results on Feb 13, 2024 Dec 22
Second quarter 2024 earnings released: EPS: JP¥21.47 (vs JP¥0.62 in 2Q 2023) Nov 16
OIZUMI Corporation to Report Q2, 2024 Results on Nov 13, 2023 Sep 28
Investor sentiment deteriorates as stock falls 16% Aug 17
First quarter 2024 earnings released: EPS: JP¥3.16 (vs JP¥9.20 in 1Q 2023) Aug 12
Full year 2023 earnings released: EPS: JP¥75.17 (vs JP¥17.29 in FY 2022) May 17
OIZUMI Corporation, Annual General Meeting, Jun 29, 2023 May 13
Upcoming dividend of JP¥12.00 per share at 2.5% yield Mar 23
Third quarter 2023 earnings released: EPS: JP¥2.31 (vs JP¥6.85 in 3Q 2022) Feb 15 OIZUMI Corporation Provides Dividend Guidance for the Year Ending March 31, 2023
OIZUMI Corporation to Report Q3, 2023 Results on Feb 13, 2023 Dec 28
Investor sentiment improved over the past week Dec 27
Second quarter 2023 earnings released: EPS: JP¥0.62 (vs JP¥0.31 in 2Q 2022) Nov 17
No independent directors Nov 16 Oizumi Corporation Announces Dividend Guidance for the Year Ending March 31, 2023
OIZUMI Corporation to Report Q2, 2023 Results on Nov 14, 2022 Sep 28
OIZUMI Corporation (TSE:6428) Signed a share transfer agreement to acquire Takeuchi Pharmaceutical Co., Ltd from Saju Kanemitsu and 4 other individual shareholders. Aug 20
First quarter 2023 earnings released: EPS: JP¥9.20 (vs JP¥18.40 in 1Q 2022) Aug 14
OIZUMI Corporation to Report Q1, 2023 Results on Aug 12, 2022 Jul 02
Full year 2022 earnings released: EPS: JP¥17.29 (vs JP¥52.54 in FY 2021) May 19
OIZUMI Corporation, Annual General Meeting, Jun 29, 2022 May 14
No independent directors Apr 27
OIZUMI Corporation to Report Fiscal Year 2022 Results on May 13, 2022 Apr 08
Investor sentiment improved over the past week Apr 06
Upcoming dividend of JP¥9.00 per share Mar 23
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 12 OIZUMI Corporation Provides Earnings Guidance for the Third Quarter of Fiscal Year Ending March 31, 2022
Investor sentiment deteriorated over the past week Nov 18
Second quarter 2022 earnings released: EPS JP¥0.31 (vs JP¥5.78 in 2Q 2021) Nov 12
Full year 2021 earnings released: EPS JP¥52.54 (vs JP¥40.59 in FY 2020) May 15
Upcoming dividend of JP¥9.00 per share Mar 23
OIZUMI Corporation to Report Fiscal Year 2021 Results on May 13, 2021 Mar 13
Third quarter 2021 earnings released: EPS JP¥22.23 (vs JP¥5.60 in 3Q 2020) Feb 14
New 90-day high: JP¥429 Jan 04
OIZUMI Corporation to Report Q3, 2021 Results on Feb 12, 2021 Dec 19
OIZUMI Corporation to Report Q2, 2021 Results on Nov 13, 2020 Sep 26
OIZUMI Corporation to Report Q1, 2021 Results on Aug 12, 2020 Jun 28
Financial Position Analysis
Short Term Liabilities: 6428's short term assets (¥20.0B) exceed its short term liabilities (¥9.1B).
Long Term Liabilities: 6428's short term assets (¥20.0B) exceed its long term liabilities (¥14.4B).
Debt to Equity History and Analysis
Debt Level: 6428's net debt to equity ratio (51.4%) is considered high .
Reducing Debt: 6428's debt to equity ratio has increased from 88.8% to 95% over the past 5 years.
Debt Coverage: 6428's debt is not well covered by operating cash flow (0.5%).
Interest Coverage: 6428's interest payments on its debt are well covered by EBIT (13.4x coverage).
Discover healthy companies Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":false,"variant":{"name":"disabled","enabled":false},"flagsReady":false,"flagsError":null}
